Enabling cell culture technologies for the intensification & scale-up of viral vector manufacturing

National Research Council Canada,
Human Health Therapeutics Research Center

 “For as long as the pressure to reduce the cost of goods for gene therapy manufacturing persists, novel cell culture platforms and continuous improvement in the production of AAV and other relevant viral vectors will be needed.” 

Please enter your email to access content Read now